Trial Profile
Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Diagnostic use
- 20 Sep 2021 Status changed from active, no longer recruiting to completed.
- 10 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 07 Aug 2018 Status changed from not yet recruiting to recruiting.